Urovant’s new overactive bladder (OAB) drug Gemtesa (vibegron) is approved by the FDA
Urovant’s new overactive bladder (OAB) drug Gemtesa (vibegron) is approved by the FDA
… Urovant’s New Overactive Bladder Drug Gemtesa (vibegron) is FDA approved …

UROVANT’S NEW OAB DRUG GEMTESA (vibegron) EARNS FDA APPROVAL

The approval of Gemtesa is a strategic corporate milestone for Urovant

Urovant is a business unit of a larger global conglomerate

Written by

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store